Document is current
Any future updates will be listed below
-
Authors
Wang, Hui
Zhang, Qian
Wu, Sensen
Pan, Dikang
Ning, Yachan
Wang, Cong
Guo, Jianming
Gu, Yongquan https://orcid.org/0000-0002-2869-9736
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (No.2021YFC2500500)
- License Information
-
More Information
Article History
Received: 30 January 2024
Accepted: 4 September 2024
First Online: 16 September 2024
Declarations
:
: This clinical study was approved by the ethical committee board of ShangRao Jingkai Health-Biotech United Hospital, the title of the approved project is: Clinical study on perinatal tissue mesenchymal stem cells in the treatment of severe lower limb ischemia (Approval number: 2021001; Date of approval: June 25, 2021). The patient provided written informed consent prior to participation in this study. Placenta and umbilical cord donors have signed informed consent for stem cell extraction, use by others, and publication of articles.
: The parents of the patients included in this study have been informed about the relevant details of the study and the associated clinical outcomes, and they have signed written consent forms supporting the publication of this research.
: The authors declare that they have no competing interests.
